alpha-aminopyridine has been researched along with Candidiasis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kapoor, M; Moloney, M; Pillar, CM; Shaw, KJ; Soltow, QA | 1 |
| Chandra, S; Joshi, T; Pundir, H | 1 |
| Lockhart, SR | 1 |
| Abe, S; Asada, M; Hata, K; Horii, T; Inoue, S; Matsukura, M; Miyazaki, M; Murai, N; Nakamoto, K; Okubo, M; Shirotori, S; Sonoda, J; Tanaka, K; Watanabe, NA; Yoshimatsu, K | 1 |
| Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA; Watanabe, N | 1 |
| Hata, K; Horii, T; Miyazaki, M; Sagane, K; Tsukahara, K; Watanabe, NA | 1 |
1 review(s) available for alpha-aminopyridine and Candidiasis
| Article | Year |
|---|---|
Candida auris and multidrug resistance: Defining the new normal.
Topics: 14-alpha Demethylase Inhibitors; Aminopyridines; Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Humans; Isoxazoles; Microbial Sensitivity Tests; Pyridines; Tetrazoles | 2019 |
5 other study(ies) available for alpha-aminopyridine and Candidiasis
| Article | Year |
|---|---|
Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in
Topics: Acyltransferases; Amino Acid Sequence; Aminopyridines; Antifungal Agents; Biosynthetic Pathways; Candida; Candidiasis; Drug Resistance, Fungal; Fungal Proteins; Genes, Fungal; Glycosylphosphatidylinositols; Humans; Isoxazoles; Membrane Proteins; Microbial Sensitivity Tests; Mutation; Saccharomyces cerevisiae Proteins; Sequence Homology, Amino Acid; Species Specificity | 2019 |
Deep-learning based repurposing of FDA-approved drugs against
Topics: Aminopyridines; Antifungal Agents; Benzodioxoles; Candida albicans; Candidiasis; Cyclopropanes; Deep Learning; Drug Approval; Drug Repositioning; Folic Acid Antagonists; Humans; Lactams, Macrocyclic; Molecular Docking Simulation; Molecular Dynamics Simulation; Proline; Rifampin; Sulfonamides; Tetrahydrofolate Dehydrogenase; United States; United States Food and Drug Administration | 2022 |
Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis.
Topics: Aminopyridines; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Candida albicans; Candida tropicalis; Candidiasis; Female; Fusariosis; Fusarium; Isoxazoles; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 2011 |
Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods.
Topics: Aminopyridines; Antifungal Agents; Candida; Candidiasis; Drug Discovery; Europe; Glycosylphosphatidylinositols; Humans; Isoxazoles; Microbial Sensitivity Tests | 2011 |
E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis.
Topics: Acylation; Aminopyridines; Antifungal Agents; Candida albicans; Candidiasis; Fungal Proteins; Gene Expression Regulation, Fungal; Glycosylphosphatidylinositols; Humans; Hyphae; Inositol; Isoxazoles; Virulence; Virulence Factors | 2012 |